Will Adams

Will Adams is a highly accomplished individual with an impressive academic and professional background in the biomedical engineering field. He holds a BS, MS, and PhD from Harvard University and has worked in various organizations such as Brigham & Women's Hospital, AstraZeneca, and Firefly Bioworks.

As the CEO, President, and Co-founder of Riparian Pharmaceuticals, Inc., Will Adams brings a wealth of experience and knowledge to the table. He has been recognized for his work in the biotech industry, as evidenced by his past fellowships in the Startup Leadership Program and his role as Scientific Consultant at Firefly Bioworks.

With a passion for research, Will Adams has also served as a Research Fellow at Harvard Medical School, where he explored the intersection between applied mathematics and biomedical engineering. He has also dabbled in teaching as a Teaching Fellow at Harvard University.

Overall, Will Adams' impressive background and accomplishments speak to his dedication and expertise in the field of biomedical engineering and biotech. He is an asset to any organization he works with and a valuable contributor to the industry as a whole.